Translational research services for accelerated discovery of antimalarial drugs
TRANSMAL aims at implementing a commercial, fee-for-service platform for cost-effective evaluation of the efficacy of antimalarial drugs. The development of such treatments is key to meet the goal of global malaria elimination, but hampered by a lack of predictive pre-clinical models with sufficient throughput and level of standardization. TRANSMAL will deliver enabling technology in the form of industrial-quality in vitro and in vivo models to predict the efficacious dose of candidate drugs.
2 378 750.00€
Pharmaceutical Products / Drugs